SN
Sanofi
SNY · NASDAQ
$42.77 -0.09% (-$0.04)
1M -2.17%
Market Cap 91.5B €
P/E Ratio 23.12x
Div. Yield 5.46%
ROE 5.52%
Bulios Fair Price
$53.77
25.7% upside
Current Price
$42.77
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
84 /100
Cheap P/E 23.12x
EV/EBITDA 8.76x
P/S 1.87x
Growth
38 /100
Stable EPS growth 0.21%
Rev. growth 4.82%
FCF growth 6.81%
Profitability
80 /100
Strong Gross margin 73.02%
Net margin 8.09%
Op. margin 14.80%
Quality
28 /100
Poor ROIC 5.33%
ROE 5.52%
ROA 3.07%
Debt
82 /100
Low Debt/Equity 0.34x
Current ratio 0.99x
Int. coverage 15.04x
Stability
65 /100
Moderate Beta 0.28x
Rev. volatility 1.98%
EPS volatility 39.36%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
76,493
Headquarters
Paris
Upcoming events
30 OCT
Earnings
Upcoming earnings report